In baroreceptor stimulation an electrode and a pacemaker are implanted near the carotid artery. They send signals that make the body lower blood pressure. The effect already begins during the surgery.
Bioelectronic medicine is embryonic. But British drugmaker GlaxoSmithKline and US tech firm Alphabet see its potential. With one eye on research and another on your data, they will jointly invest millions.
© 2018 Deutsche Welle |
Legal notice |
| Mobile version